PTCT - PTC Therapeutics Inc. (PTCT) Q1 2024 Earnings Call Transcript

2024-04-25 23:52:09 ET

PTC Therapeutics, Inc. (PTCT)

Q1 2024 Earnings Conference Call

April 25, 2024 16:30 ET

Company Participants

Jane Hanlon - Associate Director of Investor Relations

Matthew Klein - Chief Executive Officer

Eric Pauwels - Chief Business Officer

Kylie O’Keefe - Chief Commercial Officer

Pierre Gravier - Chief Financial Officer

Conference Call Participants

Kristen Kluska - Cantor Fitzgerald

Eric Joseph - JPMorgan

Kelly Shi - Jefferies

Samantha Corwin - William Blair

Joseph Thome - TD Cowen

Gena Wang - Barclays

Jeff Hung - Morgan Stanley

David Lebowitz - Citi

Danielle Brill - Raymond James

Tazeen Ahmad - Bank of America

Paul Choi - Goldman Sachs

Presentation

Operator

Good day and thank you for standing by. Welcome to PTC First Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Jane Hanlon, Associate Director of Investor Relations. Please go ahead.

Jane Hanlon

Good afternoon and thank you for joining us today to discuss PTC Therapeutics first quarter 2024 corporate update and financial results. I'm joined today by our Chief Executive Officer, Dr. Matthew Klein, our Chief Business Officer, Eric Pauwels; our Chief Commercial Officer, Kylie O'Keefe; and our Chief Financial Officer, Pierre Gravier.

Today's call will include forward-looking statements based on our current expectations. Please take a moment to review the slide posted on our Investor Relations website in conjunction with the call which contains our forward-looking statements. Our actual results could materially differ from these forward-looking statements as such statements are subject to risks that can materially and adversely affect our business and results of operations. For a detailed description of applicable risks and uncertainties, we encourage you to review the company's most recent quarterly report on Form 10-Q and annual report on Form 10-K filed with the Securities and Exchange Commission as well as the company's other SEC filings....

For further details see: